ABL Bio
298380.KQ
19.24 USD
-0.54
-2.73%
a
Overview
Last close
19.24 usd
Market cap
924.63M usd
52 week high
30.50 usd
52 week low
11.47 usd
Target price
33.75 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
40.212
Price/Book Value
930.0857
Enterprise Value
847.48M usd
EV/Revenue
36.772
EV/EBITDA
-32.1061
Key financials
Revenue TTM
23.50M usd
Gross Profit TTM
47.93M usd
EBITDA TTM
-27.40M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
120.71B usd
Net debt
42.00B usd
About
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam-si, South Korea.
- Symbol298380.KQ
- ExchangeKQ
- IsinKR7298380007
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Sang Hoon Lee Ph.D.
- HeadquarterSeongnam-si
- Web sitehttps://www.ablbio.com
